NCT04617249 is a NA clinical trial of median anesthesia in Anesthesia, sponsored by Aljazeera Hospital.

Who is sponsoring NCT04617249?

NCT04617249 is sponsored by Aljazeera Hospital.

What drugs are being tested in NCT04617249?

Interventions in NCT04617249: median anesthesia, paramedian anesthesia.

What condition does NCT04617249 study?

NCT04617249 studies Anesthesia.

Is NCT04617249 still recruiting?

NCT04617249 is currently status unknown. Last updated 5 November 2020.

Last reviewed 2020-11-05 · How we verify

NCT04617249

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Median and Paramedian Anesthesia in Cesarean Section

Status unknown NA Last updated 5 November 2020

What this trial tests

NA trial testing median anesthesia in Anesthesia in 80 participants. Status unknown.

Timeline

5 November 2020

Primary endpoint
25 April 2021

15 May 2021

Quick facts

Lead sponsor	Aljazeera Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	80
Start date	5 November 2020
Primary completion	25 April 2021
Estimated completion	15 May 2021
Sites	1 location across Egypt

Drugs / interventions tested

median anesthesia
paramedian anesthesia

Conditions studied

Anesthesia — all drugs for Anesthesia →

Sponsor

Aljazeera Hospital

Who can join

Adults 18 to 42, female only, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The number of cesarean sections worldwide has markedly been increasing since 1985.Intrathecal anesthesia is preferred by most anesthesiologists over general anesthesia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other Aljazeera Hospital trials

Trials by the same sponsor.

NCT06739759 — Ovarian Hyperstimulation Syndrome Prevention · NA · recruiting
NCT04778319 — Hysterosalpingography and Hysteroscopy in ICSI · NA · unknown
NCT04736095 — 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas · completed
NCT04749979 — Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin · NA · unknown
NCT04694677 — Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04617249 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aljazeera Hospital
Last refreshed: 5 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04617249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing